Basel Medical Group (BMGL) Stock Price, News & Analysis

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Key Stats

• Today's Range: $2.02 to $2.12
• 50-Day Range: $1.61 to $5.09
• 52-Week Range: $0.91 to $9.40
• Volume: 106,398 shs
• Average Volume: 2.30 million shs
• Market Capitalization: $38.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BMGL Stock Analysis - Frequently Asked Questions

How have BMGL shares performed this year?

Basel Medical Group's stock was trading at $4.50 at the beginning of the year. Since then, BMGL shares have decreased by 54.2% and is now trading at $2.06.

When did Basel Medical Group IPO?

Basel Medical Group (BMGL) raised $9 million in an initial public offering (IPO) on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00 per share.

When does the company's lock-up period expire?

Basel Medical Group's lock-up period expires on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its initial public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of Basel Medical Group?

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:BMGL
• CIK: 2004489
• Web: N/A
• Phone: (656) 291-9188
• Fax: N/A
• Employees: 36
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 18,450,000
• Free Float: N/A
• Market Cap: $38.01 million
• Optionable: N/A
• Beta: N/A